IMARC Group’s latest research report, titled “Heparin Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the heparin market growth. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global heparin market size reached US$ 7.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2028, exhibiting a growth rate (CAGR) of 2.4% during 2023-2028.

Heparin Market Overview:

Heparin (C12H19NO20S3) refers to a mucopolysaccharide with antithrombotic properties that acts as an anticoagulant or a blood thinner in pharmaceuticals. Heparin can be obtained from the liver, the lungs, mast cells, and other cells of vertebrates. It functions by inactivating thrombin and preventing the conversion of fibrinogen to fibrin which prevents the clots from becoming larger and causing more serious problems. The action of heparin in vitro and in vivo inhibits the formation of fibrin clots and the clotting of blood. Patients with unstable angina and heart-related conditions, such as acute coronary syndrome, thrombosis, and atrial fibrillation, may benefit from the use of this drug. For breaking up clots and maintaining smooth blood flow, heparin is usually injected directly into muscles or veins. It is extensively utilized in post-operative care, dialysis and blood transfusion procedures, and major orthopedic procedures, such as hip and knee replacements, for a quicker recovery.

Get Free Sample Copy of Report at –  https://www.imarcgroup.com/heparin-market/requestsample

Global Heparin Market Trends:

The global market is majorly driven by the rising incidences of chronic health conditions, such as renal impairment, hypertension, diabetes, and cardiovascular conditions among the masses. This can be attributed to the sedentary lifestyles and unhealthy food habits of the population. In line with this, the augmenting geriatric population that is more susceptible to developing these disorders is providing an impetus to the heparin market.

Moreover, continual technological advancements in the development of synthetic and semi-synthetic heparin mimetics are creating lucrative growth opportunities in the market. Additionally, the advent of ultra-low molecular weight heparin for chemotherapy, innovative medicines with reduced side-effects and effective carbohydrate synthesis procedures are positively impacting the market.

The market is further propelled by the rising healthcare expenditure, along with the rising government investments in enhancing healthcare services on the global level. Apart from this, numerous strategies adopted by the key players, such as mergers and acquisitions (M&As) and partnerships and collaborations to enhance their geographical presence are fueling the market. Some of the other factors contributing to the market include rapid urbanization, considerable growth in the pharmaceutical industry, inflating disposable income levels of the consumers and extensive research and development (R&D) activities.

Do you know more information, Contact to our analyst at– https://www.imarcgroup.com/heparin-market

Key Market Segmentation:

 Top Heparin Companies Worldwide:

• GlaxoSmithKline
• Hepalink
• Pfizer
• LeoPharma
• Sanofi
• Reddy’s Laboratories
• Teva Pharmaceutical Industries
• Aspen
• LEO Pharma
• Baxter
• Changshan Pharm
• Sandoz
• Opocrin
• Deebio
• Tiandong

Market Breakup by Product:

• Unfractionated Heparin
• Low Molecular Weight Heparin (LMWH)
• Ultra-low Molecular Weight Heparin (ULMWH)

Market Breakup by Source:

• Bovine
• Porcine

Market Breakup by Mode of Administration:

• Oral
• Parenteral

Market Breakup by Application:

• Atrial Fibrillation & Heart Attack
• Stroke
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Others

Market Breakup by End-User:

• Hospitals
• Clinics
• Homecare Settings
• Ambulatory Surgical Centers
• Others

Market Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Stores
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800